1. Home
  2. DX vs AVDL Comparison

DX vs AVDL Comparison

Compare DX & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DX
  • AVDL
  • Stock Information
  • Founded
  • DX 1987
  • AVDL 2015
  • Country
  • DX United States
  • AVDL Ireland
  • Employees
  • DX N/A
  • AVDL N/A
  • Industry
  • DX Real Estate Investment Trusts
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • DX Real Estate
  • AVDL Health Care
  • Exchange
  • DX Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • DX 1.7B
  • AVDL 1.8B
  • IPO Year
  • DX N/A
  • AVDL 1996
  • Fundamental
  • Price
  • DX $14.00
  • AVDL $21.37
  • Analyst Decision
  • DX Buy
  • AVDL Buy
  • Analyst Count
  • DX 4
  • AVDL 9
  • Target Price
  • DX $13.33
  • AVDL $18.38
  • AVG Volume (30 Days)
  • DX 4.9M
  • AVDL 2.7M
  • Earning Date
  • DX 10-20-2025
  • AVDL 11-04-2025
  • Dividend Yield
  • DX 14.64%
  • AVDL N/A
  • EPS Growth
  • DX 35.65
  • AVDL N/A
  • EPS
  • DX 1.66
  • AVDL N/A
  • Revenue
  • DX $230,447,000.00
  • AVDL $248,517,000.00
  • Revenue This Year
  • DX N/A
  • AVDL $64.21
  • Revenue Next Year
  • DX $134.14
  • AVDL $30.80
  • P/E Ratio
  • DX $8.39
  • AVDL N/A
  • Revenue Growth
  • DX 87.09
  • AVDL 79.88
  • 52 Week Low
  • DX $10.79
  • AVDL $6.38
  • 52 Week High
  • DX $14.52
  • AVDL $23.57
  • Technical
  • Relative Strength Index (RSI)
  • DX 69.96
  • AVDL 60.32
  • Support Level
  • DX $13.20
  • AVDL $22.72
  • Resistance Level
  • DX $13.79
  • AVDL $23.18
  • Average True Range (ATR)
  • DX 0.20
  • AVDL 0.41
  • MACD
  • DX 0.01
  • AVDL -0.01
  • Stochastic Oscillator
  • DX 96.36
  • AVDL 55.28

About DX Dynex Capital Inc.

Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: